BNR — Burning Rock Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,263	1,497	908	629	526
Net Total Accounts Receivable
Net Total Receivables	147	158	170	168	173
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,524	1,821	1,259	884	777
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	111	406	300	144	100
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,663	2,279	1,587	1,040	885
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	242	372	411	263	266
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	242	433	429	272	304
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,421	1,845	1,158	768	581
Total Liabilities & Shareholders' Equity	2,663	2,279	1,587	1,040	885
Total Common Shares Outstanding